BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 17317305)

  • 21. Cortical inhibition in Parkinson's disease: new insights from early, untreated patients.
    Cantello R; Tarletti R; Varrasi C; Cecchin M; Monaco F
    Neuroscience; 2007 Nov; 150(1):64-71. PubMed ID: 17964730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.
    Nicoletti G; Rizzo G; Barbagallo G; Tonon C; Condino F; Manners D; Messina D; Testa C; Arabia G; Gambardella A; Lodi R; Quattrone A
    Radiology; 2013 Jun; 267(3):843-50. PubMed ID: 23329659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease.
    Rascol O; Sabatini U; Fabre N; Senard JM; Simonetta-Moreau M; Montastruc JL; Clanet M; Rascol A
    Mov Disord; 1995 Mar; 10(2):163-70. PubMed ID: 7753058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
    Yekhlef F; Ballan G; Macia F; Delmer O; Sourgen C; Tison F
    J Neural Transm (Vienna); 2003 Feb; 110(2):151-69. PubMed ID: 12589575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum prolactin levels in Parkinson's disease and multiple system atrophy.
    Winkler AS; Landau S; Chaudhuri KR
    Clin Auton Res; 2002 Oct; 12(5):393-8. PubMed ID: 12420085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy.
    Holmberg B; Johnels B; Blennow K; Rosengren L
    Mov Disord; 2003 Feb; 18(2):186-90. PubMed ID: 12539213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
    Federico F; Simone IL; Lucivero V; Iliceto G; De Mari M; Giannini P; Mezzapesa DM; Tarantino A; Lamberti P
    Mov Disord; 1997 Nov; 12(6):903-9. PubMed ID: 9399213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Hussl A; Mahlknecht P; Scherfler C; Esterhammer R; Schocke M; Poewe W; Seppi K
    Mov Disord; 2010 Oct; 25(14):2444-9. PubMed ID: 20878992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms.
    Pellecchia MT; Longo K; Manfredi M; Lucetti C; Cossu G; Petrone A; Marconi R; Sensi M; Epifanio A; Eleopra R; Marchese R; Scaravilli T; Morgante L; Abbruzzese G; Bonuccelli U; Donati E; Pivonello R; Colao A; Barone P
    Mov Disord; 2008 Jan; 23(2):190-4. PubMed ID: 18044703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interrelationship between non-motor symptoms in Atypical Parkinsonism.
    Lee CN; Kim M; Lee HM; Jang JW; Lee SM; Kwon DY; Park KW; Koh SB
    J Neurol Sci; 2013 Apr; 327(1-2):15-21. PubMed ID: 23428208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
    Kim KJ; Jeong SJ; Kim JM
    Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression in multiple system atrophy and in idiopathic Parkinson's disease: a pilot comparative study.
    Pilo L; Ring H; Quinn N; Trimble M
    Biol Psychiatry; 1996 May; 39(9):803-7. PubMed ID: 8731521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striated anal sphincter denervation in patients with progressive supranuclear palsy.
    Valldeoriola F; Valls-Solé J; Tolosa ES; Marti MJ
    Mov Disord; 1995 Sep; 10(5):550-5. PubMed ID: 8552104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
    Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
    J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Tong J; Fitzmaurice PS; Ang LC; Furukawa Y; Guttman M; Kish SJ
    Ann Neurol; 2004 Jan; 55(1):125-9. PubMed ID: 14705122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
    Lee EA; Kim BJ; Lee WY
    Mov Disord; 2002 Nov; 17(6):1242-7. PubMed ID: 12465063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
    Lass P; Sławek J; Derejko M; Dubaniewicz M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.
    Ozsancak C; Auzou P; Dujardin K; Quinn N; Destée A
    J Neurol; 2004 Nov; 251(11):1317-23. PubMed ID: 15592726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebellar dysfunction in progressive supranuclear palsy: a transcranial magnetic stimulation study.
    Shirota Y; Hamada M; Hanajima R; Terao Y; Matsumoto H; Ohminami S; Tsuji S; Ugawa Y
    Mov Disord; 2010 Oct; 25(14):2413-9. PubMed ID: 20818672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.